SEC Tracker
Get the app

Medicus Pharma MDCX

Medicus Pharma announces proxy meeting

Preliminary proxy statement

Form
PRE 14A
Filed
Importance
Routine
  1. Special meeting of shareholders on December 2, 2026
  2. Proposal to create Class A Preferred Shares
  3. Share split authorization up to 1:50 ratio
  4. Adjournment proposal if needed

Written from the PRE 14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Medicus Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Champions Oncology CSBR public float $29M, Oct 31, 2025
  2. OnKure Therapeutics OKUR public float $28M, Jun 30, 2025
  3. Rockwell Medical RMTI public float $29M, Jun 30, 2025
  4. Cumberland Pharmaceuticals CPIX public float $29M, Jun 30, 2025
  5. ProMIS Neurosciences PMN public float $30M, Jun 30, 2025